- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
TSTL
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Tristel plc · Healthcare · Medical Instruments & Supplies
Latest close
410.0 GBP
-3.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 3.1% above the Trend Line and sits at 60.1% of its 52-week range. The latest completed week returned -3.8%, after a 5.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 56/100.
Setup score
52
out of 100
Latest Close
410.0 GBP
7 Aug 2026
1W Return
-3.8%
latest completed week
4W Return
5.8%
short-term follow-through
12W Return
-0.6%
quarterly tape
Trend Breadth
38.5%
20 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 35.58% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.8%
Latest completed week; four-week move 5.8%.
Indicator stack
21/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 35.58%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
56/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 3.1% above the Trend Line and sits at 60.1% of its 52-week range. The latest completed week returned -3.8%, after a 5.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2712-week average 0.23
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.27Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 5.8% over four weeks, -0.6% over 12 weeks, and 7.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.77Latest activity-pressure read.
Pressure change633.9%Four-week change in activity pressure.
Leadership-2.60Latest relative-leadership reading.
RS change47.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 91%
Model confidence 72%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength21/100Blend of value, momentum, and quality. Underlying universe rank 80; rank 1 is best.
Value3/100Relative valuation strength. Underlying universe rank 98; rank 1 is best.
Quality98/100Profitability and accounting quality. Underlying universe rank 3; rank 1 is best.
Momentum19/100Medium-term price momentum. Underlying universe rank 82; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework31/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 29.6x Price divided by trailing earnings.
- Price / sales
- 4.2x Market value relative to trailing revenue.
- EV / EBITDA
- 17.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 80.6% Gross profit retained from each unit of revenue.
- Operating margin
- 21.0% Operating profit retained from revenue.
- Free-cash-flow margin
- 17.9% Free cash flow generated from revenue.
- Return on invested capital
- 22.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 10.8% Latest one-year revenue growth.
- EPS growth
- 2.0% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -4.3% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 3.5% Cash dividends relative to market value.
- Buyback yield
- -0.2% Net share repurchases relative to market value.
- Shareholder yield
- 3.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment56/100
Weighted news tone is neutral across 5 relevant articles.
1 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.9%Distance below the 52-week high.
13-week volatility5.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2616 weeks finished lower.
Best week+18.4%Week of 24 Jul.
Worst week-6.7%Week of 22 May.
Latest week-3.8%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains7
Flat weeks1
Modest losses14
Sharp losses2
Recent vol5.9%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split21/28Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Healthcare
4-week rank24 / 79
Group average0.0%
Trend breadth27.8%
Trend27.8%active weekly trend signals
MD44.3%positive activity pressure
RS22.8%positive relative leadership
Four-week leaders
IndustryGB Medical Instruments & Supplies
4-week rank2 / 6
Group average0.8%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD66.7%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape49/100
Trend, activity pressure, participation, and risk combine to a 49/100 tape read.
Indicator analysis30/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 2/12.
Activity pressure 0.27; No reversal markers Next-Week ExpectancyNegative 35.58%Next-week expectancy is negative with a 35.58% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors35/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 89; Small Cap Core rank 96 SVQF31/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 178.5 of 260 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment56/100Weighted news tone is neutral across 5 relevant articles.
RCS - Tristel PLC - 3T Pro commercial launch Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 410.0 GBP | -3.8% | 397.7 GBP | 403.3 GBP | 0.77 | -2.60 | 798.0K | Off |
| 31 Jul 2026 | 426.0 GBP | -5.3% | 398.2 GBP | 402.9 GBP | 0.59 | 1.29 | 982.0K | Off |
| 24 Jul 2026 | 450.0 GBP | 18.4% | 398.6 GBP | 402.5 GBP | 0.33 | 8.26 | 417.6K | Off |
| 17 Jul 2026 | 380.0 GBP | -1.9% | 397.2 GBP | 401.9 GBP | 0.10 | -7.35 | 759.6K | Off |
| 10 Jul 2026 | 387.5 GBP | -3.1% | 398.4 GBP | 401.7 GBP | 0.11 | -4.97 | 218.1K | Off |
| 3 Jul 2026 | 400.0 GBP | 1.0% | 398.8 GBP | 401.5 GBP | 0.10 | -4.02 | 67.9K | Off |
| 26 Jun 2026 | 396.0 GBP | 2.2% | 397.3 GBP | 401.2 GBP | -0.09 | -3.90 | 45.5K | Off |
| 19 Jun 2026 | 387.5 GBP | -1.1% | 396.3 GBP | 400.9 GBP | -0.10 | -5.09 | 41.9K | Off |
| 12 Jun 2026 | 392.0 GBP | 3.2% | 395.2 GBP | 400.9 GBP | -0.07 | -5.17 | 171.9K | Off |
| 5 Jun 2026 | 380.0 GBP | -0.7% | 394.5 GBP | 401.1 GBP | -0.06 | -7.39 | 120.8K | Off |
| 29 May 2026 | 382.5 GBP | -0.6% | 394.1 GBP | 401.4 GBP | 0.09 | -7.33 | 1.6M | Off |
| 22 May 2026 | 385.0 GBP | -6.7% | 393.7 GBP | 401.3 GBP | 0.04 | -7.48 | 1.3M | Off |
| 15 May 2026 | 412.5 GBP | 1.2% | 393.0 GBP | 401.0 GBP | -0.24 | 1.40 | 493.9K | Off |
| 8 May 2026 | 407.5 GBP | 0.6% | 391.1 GBP | 400.5 GBP | -0.46 | -0.38 | 829.9K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.